GlassScriptPhysician profile
Andrew Zheng
NPI 1366804809
$2,861.38
in general payments reported to CMS, 2019-2025
16 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 75% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.52 · 2021: $135 · 2022: $167 · 2023: $258 · 2024: $1,178 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,519.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $802.09 | 2024-2025 | Vabysmo, Susvimo |
| Astellas Pharma US INC | $533.32 | 2023-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $337.15 | 2024-2025 | Syfovre |
| Genentech USA, INC. | $228.04 | 2023-2025 | Vabysmo, Susvimo |
| Regeneron Healthcare Solutions, INC. | $195.98 | 2024-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $152.73 | 2024-2025 | |
| Dutch Ophthalmic, USA | $151.36 | 2022 | |
| Alcon Vision LLC | $135.46 | 2021 | |
| Alimera Sciences, INC. | $107.04 | 2024 | Iluvien, Yutiq |
| Harrow Eye, LLC | $54.44 | 2025 | Triesence, Iheezo |
| Ani Pharmaceuticals, INC. | $47.44 | 2025 | Iluvien, Purified Cortrophin Gel |
| Coherus Oncology, INC. | $21.72 | 2023 | |
| Allergan, INC. | $21.52 | 2020 | |
| Sandoz INC. | $20.54 | 2024 | Cimerli |
| Bausch & Lomb Americas INC. | $19.33 | 2024 | Xipere |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $15.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Zheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.